UTHR

$UTHR chatter on StockTwits

• 
  The mann@clanBullish29m

  @amsteliam @mikesmiltaria Mikesmil, I get tired of the nonsense folks rattle out on here about, "Mannkind could not ..." or "Mannkind can't ..." Mannkind now has its ducks 🦆🦆🦆 in a row and ad & sales investments have been made/spent. Give it time to work. Mannkind today is completely different that the Mannkind 10 years ago, and also diffent than the Mannkind ... of just last year. The longer Mannkind holds off a buyout, the more Revenues grow, the more cash builds, the further the pipeline advances, and ... the higher $MNKD will climb. $SPY 👀 🇺🇲 $UTHR

  View on StockTwits ↗
• 
  Doctorgreenback@Doctorgreenback5h

  @JustAnotherJuggler $UTHR may not have that kind of time. Once again I agree with you….$6B?

  View on StockTwits ↗
• 
  Doctorgreenback@Doctorgreenback5h

  $MNKD if you are wondering why $UTHR is gonna pull the trigger sooner than later consider this. Merck recently bought Winrevair. And Liquidia market cap has ballooned as well. Two firms with massive interest in bottlenecking their competitor UTHR

  View on StockTwits ↗
• 
  Doctorgreenback@Doctorgreenback6h

  $MNKD $UTHR has $2B cash and $3.8B in total liquidity. NO debt. and 42m shares outstanding. Expecting a $5B deal for Mnkd likely followed by announcement to outsource Afrezza costs with a licensing deal. can be handled by: issuing 10m uthr shares outright which would dilute uthr holders 20%. Though they would likely announce a buyback following the stock drop Reducing the dilution by contributing more cash to the deal. Taking on debt with zero dilution and paying it off with revs from mnkd Or a combination of all 3.

  View on StockTwits ↗
• 
  Doctorgreenback@Doctorgreenback7h

  @JustAnotherJuggler admittedly I agreed with them for years. I also thought we should dump Afrezza for just as long. Things have changed and the company is going to get acquired by someone….and I’m now sure that $UTHR doesn’t want it to be somebody else. Within 2 years, we will have 3 blockbusters on our hands and own 1 of them outright. We will also own Afrezza which has been resurrected towards profitability as a Peds drug. Big pharma is constantly shifting and these companies have a bigger coffer than UTHR and are far better able to negotiate insurance using their larger portfolios. Retail still owns too much MNKD and we are range-bound as institutions pick up more shares At some point, however, this company becomes too cheap to ignore

  View on StockTwits ↗
• 
  The mann@clanBullish13h

  $UTHR 🌉 Bridge 🌁 to Tyvaso DPI and 10% to "The Big Guy", a.k.a. MannKind Corporation [ $MNKD ] $BX $LQDA $IBB

  View on StockTwits ↗
• 
  tomg9@LarryEllisonsMoustache1d

  @DontBanDan , good points . .. You know how Dan Ives and other's refer to all this as like we are still third inning at best .. the cream rises to the top and the trade ain't over by a long shot ... beside's the obvious there are folks working diligently towards delivering an ever greater future for humanity and life in general - $UTHR for example ( check out their founders story ) .. i believe we are entering a new era - the Great Convergence - man and machine synthesized .. it's still just getting started - there's no stopping it and we might as well recognize and profit from it ( if it don't work out money won't matter anyway)

  View on StockTwits ↗
• 
  Lol hahamnkd@grampslolBearish1d

  poor $MNKD pumper cultist @clan deluding himself about $UTHR gobbling up the afrezza company as he tries to deceive the naive ... a sad 🤡 indeed ...

  View on StockTwits ↗
• 
  The mann@clanBullish1d

  $MNKD Looking at the last 4 yrs, Mannkind reported Q2 earnings on either Wednesdays or Tuesdays, and between the 6th to the 9th of August. It was easy to predict that Mannkind would be reporting on this Wednesday the 5th. If anything warrants some humming and a little rubbing of one's chin🤔 is the {delay} in Unither's $UTHR earnings release, which typically comes out a week earlier. Unither and Mannkind reporting on the same day?🤔 A coinky-dinky? Maybe. Or an orchestrated duality of notice? Also, a maybe.

  View on StockTwits ↗
• 
  M@MmssmmBullish1d

  $QNCX $MRK $UTHR $JNJ $LQDA QNCX NEW COVERAGE BY OPPENHEIMER Lifesci Capital LAM-001 Orphan Drug Designation by FDA ACQUISITION COMING LOW FREE FLOAT

  View on StockTwits ↗
• 
  The mann@clanBullish1d

  $MNKD $UTHR $BX Did you know, there is a professional analyst forecasting Mannkind to generate over $110,000,000 in GAAP bottom line Net Income for 2027? That's AFTER Lasagna, et. al. pay themselves, AFTER Westlake Rent is paid, and AFTER interest on loans is covered; just to name a few expenses. Triggerring a troll🧌 in 3 ... 2 ... 1 ...

  View on StockTwits ↗
• 
  The mann@clanBullish2d

  $MNKD Mannkind Corp, Danbury, CT 🇺🇲 1. Afrezza (DPI) - the OG 2. Tyvaso DPI 3. Nintedanib DPI 4. Ralinepag DPI 5. Bumetanide DPI 6. Clofazamine DPI 7. undisclosed DPI "If the air is flowing, our powder is moving." ~ M. Castagna, CEO of Mannkind {7/29/26} #Technosphere 💯 $MRK 💪 $AMGN 🇺🇲 $UTHR

  View on StockTwits ↗
• 
  The mann@clanBullish3d

  $MNKD Word of the day, "excelerate". Is it true, $LQDA Liquidatia wants to run a combo-therapy trial using its diarrhea-causing Yutripia paired with Mannkind's Nintedanib DPI? That'd surely get $UTHR 's Martin(e)'s undies in a bunch.

  View on StockTwits ↗
• 
  Trade Hawk@TradeHawk3d

  $LQDA $UTHR Docket update

  View on StockTwits ↗
• 
  Kerry@Outcomes3d

  $MNKD $UTHR https://ir.unither.com/press-releases/2026/07-29-2026-113020821

  View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.